Atlas FDA

QIAGEN THERASCREEN KRAS RGQ PCR KIT

FDA premarket approval P110027/S004 · decided 2015-02-13

Approval details

PMA number
P110027
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
QIAGEN THERASCREEN KRAS RGQ PCR KIT
Generic name
Somatic gene mutation detection system
Applicant
QIAGEN GmbH
Date received
2015-01-21
Decision date
2015-02-13
Days to decision
23 days
Decision code
OK30
Product code
OWD
Advisory committee
Pathology
Expedited review
No
Location
Hilden
Statement
NEW ASSEMBLY LINE FOR MANUFACTURING (ASSEMBLING) QIAAMP MINELUTE SPIN COLUMNS USED TO ISOLATE AND PURIFY DNA.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
QIAstat-Dx BCID GPF Plus AMR Panel (K254194)QIAGEN GmbH2026-08-06
QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B (K254032)QIAGEN GmbH2026-03-09
QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B (K252329)QIAGEN GmbH2025-10-22
QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini (K250080)QIAGEN GmbH2025-08-27
QIAstat-Dx GI Panel 2 Mini B (K250324)QIAGEN GmbH2025-02-28
QIAstat-Dx GI Panel 2 Mini B&V (K243813)QIAGEN GmbH2025-01-08
QIAstat-Dx Meningitis/Encephalitis (ME) Panel (K242256)QIAGEN GmbH2024-10-29
QIAstat-Dx Respiratory Panel Mini (K242353)QIAGEN GmbH2024-10-25